1. Regulations
  2. title 21
  3. chapter II
  4. part 1308
  5. subjgrp 30
  6. § 1308.22

View all text of Subjgrp 30 [§ 1308.21 - § 1308.22]

§ 1308.22 - Excluded substances.

The following nonnarcotic substances which may, under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301), be lawfully sold over the counter without a prescription, are excluded from all schedules pursuant to section 201(g) (1) of the Act (21 U.S.C. 811(g) (1)):

Excluded Nonnarcotic Products

Company Trade name NDC code Form Controlled substance (mg or mg/ml) Aphena Pharma Solutions—New York, LLCNasal Decongestant Inhaler/Vapor InhalerINLevmetamfetamine (l-Desoxyephedrine)50.00 Bioline LaboratoriesTheophed00719-1945TBPhenobarbital8.00 Goldline LaboratoriesGuiaphed Elixir00182-1377ELPhenobarbital4.00 Goldline LaboratoriesTedrigen Tablets00182-0134TBPhenobarbital8.00 Hawthorne Products IncChoate's Leg FreezeLQChloral hydrate246.67 Parke-Davis & CoTedral00071-0230TBPhenobarbital8.00 Parke-Davis & CoTedral Elixir00071-0242EXPhenobarbital40.00 Parke-Davis & CoTedral S.A.00071-0231TBPhenobarbital8.00 Parke-Davis & CoTedral Suspension00071-0237SUPhenobarbital80.00 Parmed PharmacyAsma-Ese00349-2018TBPhenobarbital8.10 Procter & Gamble Co., TheVicks VapoInhaler37000-686-01INLevmetamfetamine (l-Desoxyephedrine)50.00 Rondex LabsAzma-Aids00367-3153TBPhenobarbital8.00 Smith Kline ConsumerBenzedrex49692-0928INPropylhexedrine250.00 Sterling Drug, IncBronkolixir00057-1004ELPhenobarbital0.80 Sterling Drug, IncBronkotabs00057-1005TBPhenobarbital8.00 White Hall LabsPrimatene (P-tablets)00573-2940TBPhenobarbital8.00
[38 FR 8255, Mar. 30, 1973. Redesignated at 38 FR 26609, Sept. 24, 1973, and amended at 41 FR 16553, Apr. 20, 1976; 41 FR 53477, Dec. 7, 1976; 46 FR 51603, Oct. 21, 1981; 47 FR 45867, Oct. 14, 1982; 54 FR 2100, Jan. 19, 1989; 55 FR 12162, Mar. 30, 1990; 62 FR 13968, Mar. 24, 1997; 74 FR 44283, Aug. 28, 2009; 80 FR 65634, 65637, Oct. 27, 2015; 81 FR 6453, Feb. 8, 2016]

AUTHORITY: 21 U.S.C. 811, 812, 871(b), 956(b), unless otherwise noted.

SOURCE: 38 FR 8254, Mar. 30, 1973, unless otherwise noted. Redesignated at 38 FR 26609, Sept. 24, 1973.

CITE AS: 21 CFR 1308.22